Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability and pharmacokinetics of the investigational drug 9MW3811 in healthy subjects has completed. It lists pulmonary fib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Pulmonary Fibrosis

Drugs mentioned

• 9MW3811

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Pulmonary Fibrosis, Tumor | Phase 1 | Status: COMPLETED